Brief: Adamis Pharmaceuticals Changes Name To DMK Pharmaceuticals
07/09/2023 17:18
Sept 7 (Reuters) - Adamis Pharmaceuticals Corp ADMP.O :
* ADAMIS PHARMACEUTICALS CHANGES NAME TO DMK PHARMACEUTICALS TO REFLECT NEW
STRATEGIC FOCUS
* ADAMIS PHARMACEUTICALS CORP - COMPANY'S COMMON STOCK IS EXPECTED TO TRADE
UNDER
NEW NASDAQ TICKER SYMBOL "DMK" ON OR ABOUT SEPTEMBER 8
* ADAMIS PHARMACEUTICALS CORP - DPI-125 WILL BE OUR CORE FOCUS
* ADAMIS PHARMACEUTICALS CORP - DMK EXPECTS SEVERAL POTENTIAL SIGNIFICANT
MILESTONES FOR DPI-125 BY END OF 2024
Source text for Eikon: ID:nGNX4Yx9ms
Further company coverage: ADMP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DMK Pharmaceuticals
See all newsBrief: Dmk Pharmaceuticals Corp Says Ebrahim Versi Resigned As Chairman
Brief: ZMI Pharma Finalized Acquisition Of All Strategic Assets Necessary To Manufacture Zimhi From Dmk Pharma
Brief: DMK Pharmaceuticals Files For Chapter 11 Bankruptcy In The U.S. - Court Filing
Brief: Dmk Pharmaceuticals Regains Full Rights To Commercialize Zimhi
Brief: DMK Pharmaceuticals Regains Full Rights From US Worldmeds For Symjepi And Provides Corporate Update